awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34416115-5B7BCE5E-BD3F-43C8-81D5-5189C6F3D5AC
Q34416115-5B7BCE5E-BD3F-43C8-81D5-5189C6F3D5AC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34416115-5B7BCE5E-BD3F-43C8-81D5-5189C6F3D5AC
A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study.
P2860
Q34416115-5B7BCE5E-BD3F-43C8-81D5-5189C6F3D5AC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34416115-5B7BCE5E-BD3F-43C8-81D5-5189C6F3D5AC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
72c84f6b5fd3f07fba19a195f70c5ebae5c168d9
P2860
Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials